- Peter Wetherall | August 27, 2008 10:05 PM |
Category:
FDA & Prescription DrugsSandoz Inc., recently received a Warning Letter, 08-ATL-13, from the FDA, advising Sandoz that an inspection of Sandoz's manufacturing facility located at 4700 Sandoz Drive, Wilson, North Carolina...
- Peter Wetherall | August 26, 2008 10:35 PM |
Category:
FDA & Prescription DrugsAn FDA MedWatch Alert released Thursday, August 21, informed healthcare professionals that the FDA is investigating a report from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial of a...
- Peter Wetherall | August 26, 2008 8:33 PM |
Category:
FDA & Prescription DrugsLast week, physicians came to the aid of Plaintiff's lawyers, citizens of Clark County and the American consumer of prescription medication. The editors of the New England Journal of Medicine...
- Peter Wetherall | August 22, 2008 8:45 AM |
Category:
FDA & Prescription DrugsLas Vegas consumers of generic prescription medication andAmerican consumers have much to be worried about these days. We have discussed theinefficiencies of the FDA (given its current structure...
- Peter Wetherall | August 21, 2008 8:43 AM |
Category:
FDA & Prescription DrugsNearly all published literature on neurolepticdrugs documents that akathasia is the most common type of extrapyramidalsymptom resulting from the use of metoclopramide. What is akathasia? It is...
- Peter Wetherall | August 20, 2008 8:42 AM |
Category:
FDA & Prescription DrugsThe “Warnings” section of themetoclopramide label contains a discussion of the possible side effects ofextrapyramidal symptoms. It reads: WARNINGS: Extrapyramidalsymptoms, manifested primarily as...
- Peter Wetherall | August 19, 2008 8:39 AM |
Category:
FDA & Prescription Drugs There are three ways that drugcompanies can ensure patient safety. First, of all, they can look at the adverse event reports which they arereceiving or that they get from the Food and Drug...
- Peter Wetherall | August 18, 2008 6:39 PM |
Category:
FDA & Prescription DrugsAllmanufacturers and distributors of prescription pharmaceutical products in theUnited States who hold an approved New Drug Application (hereinafter “NDA”) oran Abbreviated New Drug Application...
- Peter Wetherall | August 18, 2008 6:38 PM |
Category:
FDA & Prescription DrugsAs readers know, Reglan (the name brand) is also dispensedas Metoclopramide. Reglan wasWyeth and Schwarz Pharma’s product. But these two giant pharmaceutical companies aren’t the only...
- Peter Wetherall | August 14, 2008 4:16 PM |
Category:
FDA & Prescription DrugsThe FDA recently posted a list of 35 drugs that required safety labeling changes.http://www.fda.gov/medwatch/safety/2008/jul08_quickview.htm Readers know recent blogs discuss several unsafe drugs,...
- Peter Wetherall | August 10, 2008 9:17 PM |
Category:
FDA & Prescription DrugsClark County residents, as well as every other American consumer of prescription drug products, should consider whether the FDA is too cozy with the industry it regulates particularly in light of...
- Peter Wetherall | August 09, 2008 2:46 AM |
Category:
FDA & Prescription DrugsDiana Levine's arm was amputated after she developed gangrene from an injection of Wyeth's anti-nausea drug Phenergan. This week a brief was filed on Ms. Levine's behalf with the United States...
- Peter Wetherall | August 06, 2008 2:39 PM |
Category:
FDA & Prescription DrugsIn this blog, I continue our series on Tardive Dyskinsia, Tardive Dystonia and Akathasia, Physicians are familiar with Tardive Dyskinesia through their experiences with drugs such as Thorazine and...
- Peter Wetherall | August 05, 2008 12:51 PM |
Category:
FDA & Prescription DrugsIn the last blog, I briefly discussed Digitek. The active ingredient in Digitek is Digoxin. Digoxin overdose and digitalis toxicity can cause serious and life-threatening personal injury and...
- Peter Wetherall | August 04, 2008 9:46 PM |
Category:
Defective & Dangerous ProductsThe IB News today reported on the recall and subsequent litigation surrounding Digoxin (Digitek). As reported, Digitek "double dose" tablets were distributed to patients nationwide. ...
- Peter Wetherall | August 01, 2008 11:01 AM |
Category:
FDA & Prescription DrugsOur last blog entry discussed a severe neurological condition a person can get when ingesting Reglan (or its generic metoclopramide). If you read our other blog entries, you know this condition is...